meta-analysis | Q815382 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1016761802 |
P356 | DOI | 10.1186/1471-2407-12-526 |
P932 | PMC publication ID | 3551633 |
P698 | PubMed publication ID | 23153379 |
P5875 | ResearchGate publication ID | 233422570 |
P2093 | author name string | Peng Gao | |
Yingying Xu | |||
Huimian Xu | |||
Zhenning Wang | |||
Yongxi Song | |||
Jingxu Sun | |||
Xiaowan Chen | |||
Jiwang Liang | |||
P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
Measuring inconsistency in meta-analyses | Q27860655 | ||
Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
Epidemiology of gastric cancer | Q33788193 | ||
Clinical delivery system for intraperitoneal hyperthermic chemotherapy. | Q34268781 | ||
Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer | Q35597399 | ||
Meta-analysis of intraperitoneal chemotherapy for gastric cancer | Q35862307 | ||
A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. | Q36892244 | ||
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study | Q39013638 | ||
Recent patterns in gastric cancer: a global overview | Q39985871 | ||
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis | Q41741362 | ||
A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). | Q43798130 | ||
Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients | Q45019061 | ||
Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. | Q51468726 | ||
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. | Q51636076 | ||
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C | Q70369682 | ||
Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion | Q70783122 | ||
Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats | Q71507553 | ||
The surgical treatment of cancer of the stomach | Q72624999 | ||
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
Use of nitrogen mustard in treatment of serous effusions of neoplastic origin | Q73851004 | ||
Prospective study of peritoneal recurrence after curative surgery for gastric cancer | Q73876936 | ||
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study | Q77553200 | ||
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis | Q78168251 | ||
Selective destruction of cancers after exposure to heat | Q79372430 | ||
[Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer] | Q80691240 | ||
[Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer] | Q81631874 | ||
[Clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer] | Q83397739 | ||
Gastric cancer | Q84276928 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
chemotherapy | Q974135 | ||
meta-analysis | Q815382 | ||
P304 | page(s) | 526 | |
P577 | publication date | 2012-11-16 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials | |
P478 | volume | 12 |
Q35898235 | A Comparison of Intravenous plus Intraperitoneal Chemotherapy with Intravenous Chemotherapy Alone for the Treatment of Gastric Cancer: A Meta-Analysis |
Q37108203 | A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis |
Q28088619 | Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review |
Q26774528 | Advanced gastric cancer: What we know and what we still have to learn |
Q90609239 | Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy |
Q58768727 | Comparative effectiveness of hyperthermic intraperitoneal chemotherapy for gastric cancer: A systematic review and network meta-analysis protocol |
Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
Q26774538 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer |
Q39642640 | Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study |
Q38931710 | Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence |
Q92713103 | Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next? |
Q89953619 | Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis |
Q38156120 | Intraperitoneal chemotherapy: rationale, applications, and limitations |
Q91910752 | Issues on peritoneal metastasis of gastric cancer: an update |
Q64235347 | Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures |
Q33895603 | Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis |
Q58766340 | Peritoneal carcinomatosis |
Q34366940 | Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? |
Q53116372 | Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. |
Q36758901 | Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). |
Q90165865 | Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study |
Q90749102 | Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer-A Systematic Review |
Q39674083 | Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer |
Q36758921 | The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. |
Q58751021 | The incidence and risk factors of hepatotoxicity induced by perioperative hyperthermic intraperitoneal chemotherapy in gastrointestinal carcinoma patients: a retrospective study |
Q38201470 | The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. |
Q33621706 | The value of staging laparoscopy in gastric cancer |
Q34137285 | Towards personalized perioperative treatment for advanced gastric cancer. |
Q26744031 | Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives |